Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.

[1]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[2]  E. Levine,et al.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.

[3]  V. Terranova,et al.  Human endothelial cells are chemotactic to endothelial cell growth factor and heparin , 1985, The Journal of cell biology.

[4]  J. Rosenbaum,et al.  Modulation of endothelial cells growth induced by heparin. , 1986, Cell biology international reports.

[5]  D. Gospodarowicz,et al.  Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries , 1986, Journal of cellular physiology.

[6]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[7]  T. Imamura,et al.  Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells. , 1987, Experimental cell research.

[8]  L. Magnelli,et al.  Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells. , 1988, Thrombosis research.

[9]  J. Herbert,et al.  Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro. , 1988, Biochemical pharmacology.

[10]  D. Rifkin,et al.  Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis , 1988, The Journal of cell biology.

[11]  S. Kumar,et al.  The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.

[12]  J. Vonesch,et al.  Sulfated Polysaccharides Modulate Effects of Acidic and Basic Fibroblast Growth Factors on Repair of Injured Confluent Human Vascular Endothelium , 1989, Arteriosclerosis.

[13]  K. Thomas,et al.  Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro , 1989, Journal of cellular physiology.

[14]  G. Conn,et al.  Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Vischer,et al.  Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism. , 1991, European journal of cell biology.

[16]  H. Hämmerle,et al.  Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins. , 1991, VASA. Zeitschrift fur Gefasskrankheiten.

[17]  J. Dawes,et al.  Effects of Heparin and Endothelial Cell Growth Supplement on Haemostatic Functions of Vascular Endothelium , 1992, Thrombosis and Haemostasis.

[18]  D. Barritault,et al.  Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF , 1992, Journal of cellular physiology.

[19]  S. Kobayashi,et al.  Heparin inhibits the progression phase of subcultured endothelial cell proliferation in rat aorta. , 1992, Japanese journal of pharmacology.

[20]  M. Kiefer,et al.  Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[21]  Y. Osada,et al.  Inhibitory effects of a bacteria‐derived sulfated polysaccharide against basic fibroblast growth factor‐induced endothelial cell growth and chemotaxis , 1993, Journal of cellular physiology.

[22]  R. Williams,et al.  A revised structure for fucoidan may explain some of its biological activities. , 1993, The Journal of biological chemistry.

[23]  C. Parish,et al.  Investigation of the ability of several naturally occurring and synthetic polyanions to bind to and potentiate the biological activity of acidic fibroblast growth factor , 1993, Journal of cellular physiology.

[24]  M. Jaye,et al.  Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.

[25]  M. Rusnati,et al.  Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. , 1994, The Biochemical journal.

[26]  I. A. Santos,et al.  Minimum fragments of the heparin molecule able to produce the accumulation and change of the sulfation pattern of an antithrombotic heparan sulfate from endothelial cells. , 1995, Thrombosis and haemostasis.

[27]  A. Haegerstrand,et al.  Effects of sera, basic fibroblast growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells. , 1995, Cellular and molecular biology.

[28]  S. Alban,et al.  Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation. , 1995, Journal of cell science.

[29]  A. Ashton,et al.  Acidic and basic fibroblast growth factors have comparable effects on the haemostatic function of vascular endothelium. , 1995, Growth factors.

[30]  A. Fischer,et al.  Venous Antithrombotic and Anticoagulant Activities of a Fucoïdan Fraction , 1995, Thrombosis and Haemostasis.

[31]  B. Zetter,et al.  Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. , 1996, Growth factors.

[32]  L. Rosenfeld,et al.  Suppression of endothelin-1 production in cultured human umbilical vein endothelial cells by heparin fractions separated by strong anion exchange chromatography. , 1996, Archives of biochemistry and biophysics.

[33]  M. Schaefer,et al.  Sulfated malto‐oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation , 1996, Journal of cellular physiology.

[34]  P. Sandset.  Tissue factor pathway inhibitor (TFPI)--an update. , 1996, Haemostasis.

[35]  S. Soeda,et al.  Inhibitory effect of oversulfated fucoidan on tube formation by human vascular endothelial cells. , 1997, Biological & pharmaceutical bulletin.